These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33968740)

  • 1. Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer.
    Tian X; Wu L; Jiang M; Zhang Z; Wu R; Miao J; Liu C; Gao S
    Front Oncol; 2021; 11():641399. PubMed ID: 33968740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
    J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer.
    Tian X; Wu L; Jiang M; Zhang Z; Wu R; Miao J; Liu C; Gao S
    Front Oncol; 2022; 12():793448. PubMed ID: 35463385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsa_circ_001569 is an unfavorable prognostic factor and promotes cell proliferation and metastasis by modulating PI3K-AKT pathway in breast cancer.
    Xu JH; Wang Y; Xu D
    Cancer Biomark; 2019; 25(2):193-201. PubMed ID: 31104012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C19orf10 promotes malignant behaviors of human bladder carcinoma cells via regulating the PI3K/AKT and Wnt/β-catenin pathways.
    Li S; Mao L; Zhao F; Yan J; Song G; Luo Q; Li Z
    J Cancer; 2021; 12(14):4341-4354. PubMed ID: 34093834
    [No Abstract]   [Full Text] [Related]  

  • 6. CHN1 promotes epithelial-mesenchymal transition via the Akt/GSK-3β/Snail pathway in cervical carcinoma.
    Zhao H; Wang L; Wang S; Chen X; Liang M; Zhang X; Wang J; Xu X
    J Transl Med; 2021 Jul; 19(1):295. PubMed ID: 34238315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1ql4 regulates breast cancer cell stemness and epithelial-mesenchymal transition through PI3K/AKT/NF-κB signaling pathway.
    Xu F; Wang J; Zhen S; Duan Y; Li Q; Liu L
    Front Oncol; 2023; 13():1192482. PubMed ID: 37324011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
    Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
    Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AKR1B10 promotes breast cancer cell proliferation and migration via the PI3K/AKT/NF-κB signaling pathway.
    Qu J; Li J; Zhang Y; He R; Liu X; Gong K; Duan L; Luo W; Hu Z; Wang G; Xia C; Luo D
    Cell Biosci; 2021 Aug; 11(1):163. PubMed ID: 34419144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIFC3 Promotes Proliferation, Migration, and Invasion in Colorectal Cancer
    Liao H; Zhang L; Lu S; Li W; Dong W
    Front Genet; 2022; 13():848926. PubMed ID: 35812733
    [No Abstract]   [Full Text] [Related]  

  • 11. LncRNA SNHG6 promotes breast cancer progression and epithelial-mesenchymal transition via miR-543/LAMC1 axis.
    Wang YQ; Huang G; Chen J; Cao H; Xu WT
    Breast Cancer Res Treat; 2021 Jul; 188(1):1-14. PubMed ID: 33782812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoglycin (OGN) Inhibits Cell Proliferation and Invasiveness in Breast Cancer via PI3K/Akt/mTOR Signaling Pathway.
    Xu T; Zhang R; Dong M; Zhang Z; Li H; Zhan C; Li X
    Onco Targets Ther; 2019; 12():10639-10650. PubMed ID: 31824171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinesin family member C1 accelerates bladder cancer cell proliferation and induces epithelial-mesenchymal transition via Akt/GSK3β signaling.
    Xiao KH; Teng K; Ye YL; Tan L; Chen MK; Liang HT; Feng ZH; Duan JL; Deng MH; Wei WS; Luo JH; Qin ZK; Xie D
    Cancer Sci; 2019 Sep; 110(9):2822-2833. PubMed ID: 31278883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Chain Non-Coding SOX21-AS1 Promotes Proliferation and Migration of Breast Cancer Cells Through the PI3K/AKT Signaling Pathway.
    Sheng XY; Wang CH; Wang CF; Xu HY
    Cancer Manag Res; 2020; 12():11005-11014. PubMed ID: 33173334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of FAM83D Enhances Radiosensitivity in Coordination with Irradiation by Inhibiting EMT via the Akt/GSK-3β/Snail Signaling Pathway in Human Esophageal Cancer Cells.
    Yang XX; Ma M; Sang MX; Zhang XY; Zou NY; Zhu SC
    Onco Targets Ther; 2020; 13():4665-4678. PubMed ID: 32547096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA CirCHIPK3 promotes cell proliferation and invasion of breast cancer by sponging miR-193a/HMGB1/PI3K/AKT axis.
    Chen ZG; Zhao HJ; Lin L; Liu JB; Bai JZ; Wang GS
    Thorac Cancer; 2020 Sep; 11(9):2660-2671. PubMed ID: 32767499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling.
    Luo J; Yao JF; Deng XF; Zheng XD; Jia M; Wang YQ; Huang Y; Zhu JH
    J Exp Clin Cancer Res; 2018 Feb; 37(1):23. PubMed ID: 29426357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of CLEC3A promotes tumor progression and poor prognosis in breast invasive ductal cancer.
    Ni J; Peng Y; Yang FL; Xi X; Huang XW; He C
    Onco Targets Ther; 2018; 11():3303-3312. PubMed ID: 29892197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GINS2 facilitates epithelial-to-mesenchymal transition in non-small-cell lung cancer through modulating PI3K/Akt and MEK/ERK signaling.
    Liu X; Sun L; Zhang S; Zhang S; Li W
    J Cell Physiol; 2020 Nov; 235(11):7747-7756. PubMed ID: 31681988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LIM and SH3 protein 1 induces glioma growth and invasion through PI3K/AKT signaling and epithelial-mesenchymal transition.
    Zhong C; Li X; Tao B; Peng L; Peng T; Yang X; Xia X; Chen L
    Biomed Pharmacother; 2019 Aug; 116():109013. PubMed ID: 31146105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.